GHK (Glycine-Histidine-Lysine Tripeptide)
Also known as: GHK tripeptide, Gly-His-Lys, copper chelating tripeptide, GHK free tripeptide
GHK tripeptide is a research compound. Not approved as a drug for human use.
Overview
The free tripeptide component of GHK-Cu before copper complexation. GHK naturally occurs in human plasma, saliva, and urine and promotes wound healing, collagen synthesis, and anti-inflammatory activity. While it readily chelates copper to form GHK-Cu in vivo, research distinguishes the independent effects of free GHK from the copper-complexed form on gene expression and tissue remodeling.
Research Summary
Free GHK directly upregulates collagen, elastin, and laminin synthesis in fibroblasts through TGF-β pathway activation and metalloproteinase modulation. Loren Pickart's decades of research identified GHK as a potent tissue remodeling signal whose plasma concentrations decline with age. At physiologic concentrations, GHK resets approximately 31% of dysregulated gene expression associated with aging back toward a younger phenotype.
Dosing Range
low
0.5mg
moderate
1mg
high
2mg
Units: mg · Frequency: Daily or every other day (topical or SC)
Dosing ranges are aggregated from preclinical research and community protocols. Not medical dosing guidance.
Administration Routes
Reconstitution Notes
Dissolve in sterile water or saline for injection use. For topical use: dissolve in appropriate vehicle (glycerin-water base, liposomal formulation, or serum base). Topical stability optimized at pH 6–7.Step-by-step reconstitution guide →
Supplies you'll need
Affiliate links — Research Stack may earn a small commission at no extra cost to you.
Reported Side Effects
- Minimal reported side effects
- Mild injection site irritation
- Rare topical sensitization
- No significant systemic effects at research doses
Research Papers
2 peer-reviewed sourcesCommunity Experiences
Aggregated from public forums. Anecdotal — not clinical evidence.
Skincare community discussions on topical copper peptide formulations for anti-aging and wound healing.
View original threadResearch community discussion on injectable GHK vs. topical GHK-Cu for tissue repair.
View original threadOverview
GHK (Gly-His-Lys) is a naturally occurring tripeptide first isolated from human plasma albumin in 1973 by Loren Pickart. It circulates at concentrations that decline dramatically with age: ~200 ng/mL in young adults, falling below 80 ng/mL by age 60. This age-dependent decline coincides with reduced wound healing capacity, skin deterioration, and increased inflammatory signaling — a correlation that drove decades of GHK research.
GHK functions as a tissue repair signal. Its high affinity for copper(II) means that in the body it rapidly forms the GHK-Cu complex, which has been commercially exploited in copper peptide skincare products. However, free GHK itself has significant independent bioactivity that operates even in copper-depleted environments.
Mechanism
Independent GHK Activity (Copper-Free)
Free GHK directly activates tissue remodeling through:
- TGF-β pathway activation: Upregulates TGF-β1 and its receptors on fibroblasts → collagen type I, III synthesis
- Metalloproteinase modulation: Stimulates MMP-2 and MMP-9 (for clearing damaged matrix) while inducing TIMP-1 and TIMP-2 (preventing excessive breakdown) — a tightly regulated remodeling signal
- Anti-inflammatory gene expression: Suppresses NFκB-mediated inflammatory gene transcription
GHK-Cu (Copper Complex)
When GHK chelates copper(II), additional activities emerge:
- Superoxide dismutase (SOD) induction: Copper cofactor for antioxidant enzyme activity
- Enhanced angiogenesis: VEGF upregulation and endothelial cell migration
- Hair follicle activation: AHK-Cu is a structural variant with optimized hair follicle activity
- Wound healing acceleration: Multiple cell types respond to GHK-Cu for accelerated closure
Gene Expression Research
Pickart and colleagues used Broad Institute gene expression data to show that GHK at physiologic concentrations modulates thousands of human genes, resetting many age-associated expression changes toward younger baseline states. This broad regulatory activity has positioned GHK as a longevity research target, not merely a wound-healing peptide.
GHK vs. GHK-Cu
| Parameter | GHK | GHK-Cu | |-----------|-----|--------| | Copper content | None | Complexed Cu2+ | | Collagen synthesis | Yes | Yes (enhanced) | | Antioxidant | Limited | Enhanced (SOD) | | Topical stability | Good | Good (pH 4–5) | | Skin absorption | Good | Good | | Primary use | Injectable tissue repair | Topical anti-aging, wound healing |
Related Healing Peptides
BPC-157
HealingBody Protection Compound · PL 14736
BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. It has been extensivel…
BPC-157 + TB-500 Stack
HealingWolverine Stack · BPC TB500 combination
The most widely researched peptide stack for tissue repair, combining BPC-157 (angiogenesis and growth factor upregulati…
KPV
HealingLys-Pro-Val · Alpha-MSH C-terminal tripeptide
KPV is a C-terminal tripeptide fragment (Lys-Pro-Val) of alpha-melanocyte stimulating hormone (α-MSH). Despite its small…